• 1
    Reaven, GM (1988) Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37: 15951607.
  • 2
    Alberti, K. G., Zimmet, PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 15: 539553.
  • 3
    Balkau, B., Charles, MA (1999) Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 16: 442443.
  • 4
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 24862497.
  • 5
    Einhorn, D., Reaven, G. M., Cobin, R. H., et al (2003) American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 9: 237252.
  • 6
    Alberti, K. G., Zimmet, P., Shaw, J. (2005) The metabolic syndrome: a new worldwide definition. Lancet 366: 10591062.
  • 7
    Grundy, S. M., Cleeman, J. I., Daniels, S. R., et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 27352752.
  • 8
    Palaniappan, L., Carnethon, M. R., Wang, Y., et al (2004) Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27: 788793.
  • 9
    Karelis, A. D., St Pierre, D. H., Conus, F., Rabasa-Lhoret, R., Poehlman, ET (2004) Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 89: 25692575.
  • 10
    St Pierre, A. C., Cantin, B., Mauriege, P., et al (2005) Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 172: 13011305.
  • 11
    Cutter, J., Tan, B. Y., Chew, SK (2001) Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ 79: 908915.
  • 12
    Wilson, P. W., D'Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., Kannel, WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 18371847.
  • 13
    Hokanson, J. E., Austin, MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3: 213219.
  • 14
    Despres, J. P., Lemieux, I., Dagenais, G. R., Cantin, B., Lamarche, B. (2000) HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 153: 263272.
  • 15
    Martin, B. C., Warram, J. H., Krolewski, A. S., Bergman, R. N., Soeldner, J. S., Kahn, CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925929.
  • 16
    Haffner, S. M., Miettinen, H., Gaskill, S. P., Stern, MP (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44: 13861391.
  • 17
    Despres, J. P., Lamarche, B., Mauriege, P., et al (1996) Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 334: 952957.
  • 18
    Howard, G., O'Leary, D. H., Zaccaro, D., et al (1996) Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93: 18091817.
  • 19
    Wang, J. J., Qiao, Q., Miettinen, M. E., Lappalainen, J., Hu, G., Tuomilehto, J. (2004) The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 27: 24292437.
  • 20
    Keil, U., Chambless, L., Filipiak, B., Hartel, U. (1991) Alcohol and blood pressure and its interaction with smoking and other behavioural variables: results from the MONICA Augsburg Survey 1984–1985. J Hypertens 9: 491498.
  • 21
    Facchini, F. S., Hollenbeck, C. B., Jeppesen, J., Chen, Y. D., Reaven, GM (1992) Insulin resistance and cigarette smoking. Lancet 339: 11281130.
  • 22
    Dzien, A., Dzien-Bischinger, C., Hoppichler, F., Lechleitner, M. (2004) The metabolic syndrome as a link between smoking and cardiovascular disease. Diabetes Obes Metab. 6: 127132.
  • 23
    Villegas, R., Creagh, D., Hinchion, R., O'Halloran, D., Perry, IJ (2004) Prevalence and lifestyle determinants of the metabolic syndrome. Ir Med J. 97: 300303.
  • 24
    Zhu, S., St Onge, M. P., Heshka, S., Heymsfield, SB (2004) Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism 53: 15031511.
  • 25
    Lee, W. Y., Jung, C. H., Park, J. S., Rhee, E. J., Kim, SW (2005) Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Diabetes Res Clin Pract. 67: 7077.
  • 26
    Tonstad, S., Svendsen, M. (2005) Premature coronary heart disease, cigarette smoking, and the metabolic syndrome. Am J Cardiol. 96: 16811685.
  • 27
    Liu, J., Young, T. K., Zinman, B., Harris, S. B., Connelly, P. W., Hanley, AJ (2006) Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Obesity (Silver Spring) 14: 500508.